Lowell Therapeutics, Inc. to present at The Biotech Showcase™ 2020

Quoted from Reportable News:

San Francisco/January 12, 2020 – Lowell Therapeutics, Inc., (Lowell) today announced that it has scheduled a company presentation at the Biotech Showcase™ 2020, to be held January 13-15, during the most important week in healthcare at the Hilton San Francisco Union Square.

James Wilkie, President & CEO will be presenting Lowell Therapeutics, Inc. at Biotech Showcase as follows:

Date: Tuesday, January 14, 2020

Time: 4:00 p.m. (PST)

Room: Franciscan B (Ballroom Level)

Venue: Hilton San Francisco Union Square Hotel, San Francisco, CA (United States)

Lowell is developing anticoagulants and other therapies for critically ill patients.

“We’re very pleased with the progress our team made in 2019 and we’re excited about bringing our lead product, Niyad™, to the clinic,” said James Wilkie, Lowell’s President & CEO.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry’s largest gatherings and busiest weeks.

“We are delighted that Lowell Therapeutics, Inc. will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”


Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 12th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.


Lowell Therapeutics, Inc. is focused on the discovery, development and commercialization of innovative therapies intended to significantly improve clinical outcomes in patients. NIYAD™, a preclinical-stage investigational product, is being developed for anticoagulation of the extracorporeal circuit and in particular continuous renal replacement therapy (CRRT).


James Wilkie

President & CEO


NIYAD™ is a trademark of Lowell Therapeutics, Inc.

Follow Lowell Therapeutics on LinkedIn and Biotech Showcase on Twitter at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase.

Leave a Reply

Your email address will not be published. Required fields are marked *